Introduction: The cardiovascular complications related to COVID-19 have led to the need for echocardiographic services for these patients to help with the management and identification of complications. The aim of this study was to identify echocardiographic findings in COVID-19 infection and its utility in management. Methods: We included in our study patients who were COVID-19 positive by polymerase chain reaction test (PCR) and had echocardiogram done during the same admission. Results: A total of 45 patients were evaluated, the mean age was 61.4 ± 12.2 years. Hypertension 29 (64%) and in diabetes mellitus in 25 patients ( 55%) were the most common comorbidities followed by congestive heart failure(CHF) in 11 patients (24%), Coronary artery disease (CAD) in 9 patients (20%) and valvular heart disease in 3 patients (7%). Eight patients (18%) had of myocardial injury suggested by elevated troponin (n=44) and BNP was found to be elevated in 14 patients (35.8 %) (n=39) patients. Majority 93 % (n=29) had elevated LDH and 87.8 % (n=33) had elevated ferritin. and D dimer 88 % (n=27). 14 patients had left ventricular dysfunction (31%). 6 patients with right ventricular (RV) dilatation and 5 patients with reduced RVEF. Pressure and volume overload were seen in 3 of our patients. In one patient RV thrombus was visualized. Pulmonary pressure was found to be elevated in 10 patients (24%). Conclusion: 2-dimensional echocardiography can be an important bedside tool in the assessment of left and right ventricular function and hemodynamic status COVID-19 patients.